clarithromycin

clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.

Cross Reference

Introduction

To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with clarithromycin?

clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with clarithromycin

MeSH term MeSH ID Detail
Pseudomyxoma Peritonei D011553 1 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Prurigo D011536 4 associated lipids
Proteinuria D011507 30 associated lipids
Pneumonia, Mycoplasma D011019 6 associated lipids
Pleuropneumonia D011001 3 associated lipids
Pleural Diseases D010995 4 associated lipids
Periodontitis D010518 22 associated lipids
Periodontal Pocket D010514 9 associated lipids
Periodontal Abscess D010508 2 associated lipids
Peptic Ulcer Perforation D010439 3 associated lipids
Peptic Ulcer Hemorrhage D010438 4 associated lipids
Peptic Ulcer D010437 19 associated lipids
Parotitis D010309 4 associated lipids
Parotid Neoplasms D010307 2 associated lipids
Parotid Diseases D010305 1 associated lipids
Paronychia D010304 3 associated lipids
Parkinson Disease D010300 53 associated lipids
Pancreatitis D010195 10 associated lipids
Pain D010146 64 associated lipids
Otitis Media with Effusion D010034 9 associated lipids
Otitis Media D010033 12 associated lipids
Osteomyelitis D010019 10 associated lipids
Psittacosis D009956 4 associated lipids
Endophthalmitis D009877 12 associated lipids
Nocardia Infections D009617 6 associated lipids
Neuromuscular Diseases D009468 10 associated lipids
Nasal Polyps D009298 26 associated lipids
Myxoma D009232 1 associated lipids
Myocardial Infarction D009203 21 associated lipids
Mycobacterium Infections, Nontuberculous D009165 8 associated lipids
Monoclonal Gammopathy of Undetermined Significance D008998 2 associated lipids
Metaplasia D008679 7 associated lipids
Mastoiditis D008417 2 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Mycetoma D008271 4 associated lipids
Lymphangitis D008205 4 associated lipids
Lymphadenitis D008199 8 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Neoplasms D008175 171 associated lipids
Lung Diseases, Obstructive D008173 10 associated lipids
Lung Diseases D008171 37 associated lipids
Leprosy D007918 8 associated lipids
Leishmaniasis, Visceral D007898 13 associated lipids
Legionnaires' Disease D007877 4 associated lipids
Obstetric Labor, Premature D007752 9 associated lipids
Klebsiella Infections D007710 7 associated lipids
Keratoconjunctivitis D007637 3 associated lipids
Ischemia D007511 18 associated lipids
Iritis D007500 2 associated lipids
Iris Diseases D007499 2 associated lipids
Insulin Resistance D007333 99 associated lipids
Influenza, Human D007251 11 associated lipids
Infant, Premature, Diseases D007235 7 associated lipids
Immunoproliferative Small Intestinal Disease D007161 2 associated lipids
Hypoproteinemia D007019 1 associated lipids
Hyperlipidemias D006949 73 associated lipids
Hyperemesis Gravidarum D006939 2 associated lipids
Hypercholesterolemia D006937 91 associated lipids
HIV Seropositivity D006679 15 associated lipids
Hernia, Hiatal D006551 3 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Gastrointestinal Hemorrhage D006471 27 associated lipids
Hemophilia A D006467 10 associated lipids
Hemolysis D006461 131 associated lipids
Heart Failure D006333 36 associated lipids
Hearing Loss, Sensorineural D006319 8 associated lipids
Hearing Disorders D006311 10 associated lipids
Hand Dermatoses D006229 5 associated lipids
Granuloma, Plasma Cell D006104 1 associated lipids
Glossitis, Benign Migratory D005929 1 associated lipids
Giardiasis D005873 3 associated lipids
Gastrointestinal Diseases D005767 20 associated lipids
Gastroesophageal Reflux D005764 10 associated lipids
Gastritis, Hypertrophic D005758 1 associated lipids
Gastritis, Atrophic D005757 4 associated lipids
Gastritis D005756 27 associated lipids
Fusobacterium Infections D005674 3 associated lipids
Fractures, Open D005597 3 associated lipids
Foot Diseases D005534 4 associated lipids
Fistula D005402 8 associated lipids
Fibrosis D005355 23 associated lipids
Fever D005334 35 associated lipids
Exanthema D005076 11 associated lipids
Euthyroid Sick Syndromes D005067 1 associated lipids
Esophagitis, Peptic D004942 4 associated lipids
Erythema Nodosum D004893 5 associated lipids
Ergotism D004881 4 associated lipids
Enterocolitis, Pseudomembranous D004761 8 associated lipids
Endometriosis D004715 29 associated lipids
Encephalomyelitis, Acute Disseminated D004673 1 associated lipids
Encephalitis D004660 15 associated lipids
Empyema, Tuberculous D004654 1 associated lipids
Empyema D004653 3 associated lipids
Ecchymosis D004438 3 associated lipids
Dyspnea D004417 10 associated lipids
Dyspepsia D004415 5 associated lipids
Duodenogastric Reflux D004383 2 associated lipids
Duodenitis D004382 4 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Per page 10 20 50 100 | Total 242

PubChem Associated disorders and diseases

What pathways are associated with clarithromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with clarithromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with clarithromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with clarithromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with clarithromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with clarithromycin?

Mouse Model

Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).

Knock-out

Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).

Experimental Pneumococcal Meningitis

Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with clarithromycin

Download all related citations
Per page 10 20 50 100 | Total 7636
Authors Title Published Journal PubMed Link
Lai KC et al. Ulcer-healing drugs are required after eradication of Helicobacter pylori in patients with gastric ulcer but not duodenal ulcer haemorrhage. 2000 Aliment. Pharmacol. Ther. pmid:10930902
Pilotto A et al. Pantoprazole versus one-week Helicobacter pylori eradication therapy for the prevention of acute NSAID-related gastroduodenal damage in elderly subjects. 2000 Aliment. Pharmacol. Ther. pmid:10930903
Spinzi G et al. Randomized study comparing omeprazole plus amoxycillin versus omeprazole plus clarithromycin for eradication of Helicobacter pylori. 1997 Aliment. Pharmacol. Ther. pmid:9146769
Peterson WL The role of antisecretory drugs in the treatment of Helicobacter pylori infection. 1997 Aliment. Pharmacol. Ther. pmid:9146787
Masaoka T et al. Second-line treatment of Helicobacter pylori infection after dilution agar methods and PCR-RFLP analysis. 2004 Aliment. Pharmacol. Ther. pmid:15298608
Kondo Y et al. Helicobacter pylori eradication decreases blood neutrophil and monocyte counts. 2004 Aliment. Pharmacol. Ther. pmid:15298609
Chiba N et al. Economic evaluation of Helicobacter pylori eradication in the CADET-Hp randomized controlled trial of H. pylori-positive primary care patients with uninvestigated dyspepsia. 2004 Aliment. Pharmacol. Ther. pmid:14984382
Di Mario F et al. Bovine lactoferrin for Helicobacter pylori eradication: an open, randomized, multicentre study. 2006 Aliment. Pharmacol. Ther. pmid:16611285
Madisch A et al. Healing of lymphocytic gastritis after Helicobacter pylori eradication therapy--a randomized, double-blind, placebo-controlled multicentre trial. 2006 Aliment. Pharmacol. Ther. pmid:16441467
Wong BC et al. One-week ranitidine bismuth citrate-based triple therapy for the eradication of Helicobacter pylori in Hong Kong with high prevalence of metronidazole resistance. 2001 Aliment. Pharmacol. Ther. pmid:11207516
Fakheri H et al. Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate. 2001 Aliment. Pharmacol. Ther. pmid:11207517
Peitz U et al. High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study. 2002 Aliment. Pharmacol. Ther. pmid:11860415
Sheu BS et al. Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication. 2002 Aliment. Pharmacol. Ther. pmid:12197847
Calvet X et al. A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection. 2000 Aliment. Pharmacol. Ther. pmid:10792124
John Albert M et al. High prevalence and level of resistance to metronidazole, but lack of resistance to other antimicrobials in Helicobacter pylori, isolated from a multiracial population in Kuwait. 2006 Aliment. Pharmacol. Ther. pmid:17059517
Malfertheiner P et al. Helicobacter pylori eradication and gastric ulcer healing--comparison of three pantoprazole-based triple therapies. 2003 Aliment. Pharmacol. Ther. pmid:12752349
Gené E et al. Triple vs. quadruple therapy for treating Helicobacter pylori infection: a meta-analysis. 2003 Aliment. Pharmacol. Ther. pmid:12752350
Toracchio S et al. Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication. 2000 Aliment. Pharmacol. Ther. pmid:11121913
Drouet M et al. [Unusual clinical form of amoxicillin allergy]. 1996 Allerg Immunol (Paris) pmid:9011169
Can C et al. Symmetrical drug-related intertriginous and flexural exanthema induced by two different antibiotics. Allergol Immunopathol (Madr) pmid:23253684
Gangemi S et al. Immediate reaction to clarithromycin. 2001 Jan-Feb Allergol Immunopathol (Madr) pmid:11449533
Gaig P et al. Efficacy of the eradication of Helicobacter pylori infection in patients with chronic urticaria. A placebo-controlled double blind study. 2002 Sep-Oct Allergol Immunopathol (Madr) pmid:12396958
Karakaya G et al. Determining safe antibiotics for drug hypersensitive patients with the alternative method of double-triple test. Allergol Immunopathol (Madr) pmid:19080798
Malheiro D et al. Nimesulide-induced fixed drug eruption. 2005 Sep-Oct Allergol Immunopathol (Madr) pmid:16287549
Seitz CS et al. Suspicion of macrolide allergy after treatment of infectious diseases including Helicobacter pylori: results of allergological testing. Allergol Immunopathol (Madr) pmid:21269750
Moreira A et al. Is Helicobacter pylori infection associated with chronic idiopathic urticaria? Allergol Immunopathol (Madr) pmid:12890412
Brož P et al. Nonirritant intradermal skin test concentrations of ciprofloxacin, clarithromycin, and rifampicin. 2012 Allergy pmid:22435670
Igea JM and Lázaro M Hypersensitivity reaction to clarithromycin. 1998 Allergy pmid:9491242
Ben-Shoshan M et al. Anaphylactic reaction to clarithromycin in a child. 2009 Allergy pmid:19222423
Siddiqui S and Brightling CE Airways disease: phenotyping heterogeneity using measures of airway inflammation. 2007 Allergy Asthma Clin Immunol pmid:20525145
Xepapadaki P et al. Atypical bacteria and macrolides in asthma. 2008 Allergy Asthma Clin Immunol pmid:20525132
Desrosiers M et al. Canadian clinical practice guidelines for acute and chronic rhinosinusitis. 2011 Allergy Asthma Clin Immunol pmid:21310056
Wedi B et al. Urticaria and infections. 2009 Allergy Asthma Clin Immunol pmid:20066173
Thong BY Update on the management of antibiotic allergy. 2010 Allergy Asthma Immunol Res pmid:20358021
Park SJ et al. Fulminant and Fatal Multiple Organ Failure in a 12-Year-Old Boy With Mycoplasma pneumoniae Infection. 2012 Allergy Asthma Immunol Res pmid:22211173
Kim MH et al. A case of chlorpheniramine maleate-induced hypersensitivity with aspirin intolerance. 2011 Allergy Asthma Immunol Res pmid:21217928
Hong SJ The Role of Mycoplasma pneumoniae Infection in Asthma. 2012 Allergy Asthma Immunol Res pmid:22379599
Kariyawasam HH and Scadding GK Chronic rhinosinusitis: therapeutic efficacy of anti-inflammatory and antibiotic approaches. 2011 Allergy Asthma Immunol Res pmid:21966602
Damianos AJ and McGarrity TJ Treatment strategies for Helicobacter pylori infection. 1997 Am Fam Physician pmid:9191460
Karlstadt RG and Walker K Update on prescribing information for pantoprazole. 2003 Am Fam Physician pmid:12674447
Gregory DS Pertussis: a disease affecting all ages. 2006 Am Fam Physician pmid:16913160
Chaisson R Clarithromycin is effective against M. avium complex in AIDS. 1992 Am Fam Physician pmid:1456199
Elston D Nontuberculous mycobacterial skin infections: recognition and management. 2009 Am J Clin Dermatol pmid:19658440
Rebora A The management of rosacea. 2002 Am J Clin Dermatol pmid:12180896
Scheinfeld N Confluent and reticulated papillomatosis : a review of the literature. 2006 Am J Clin Dermatol pmid:17007541
Zeegelaar JE and Faber WR Imported tropical infectious ulcers in travelers. 2008 Am J Clin Dermatol pmid:18572973
Chang SL et al. Bilateral sporotrichoid lymphocutaneous dermatosis in a drug abuser: case report and review of the literature. 2008 Am J Clin Dermatol pmid:18973406
Wedi B and Kapp A Helicobacter pylori infection in skin diseases: a critical appraisal. 2002 Am J Clin Dermatol pmid:12010072
Curth HM et al. Effects of Helicobacter pylori Eradication in Chronic Spontaneous Urticaria: Results from a Retrospective Cohort Study. 2015 Am J Clin Dermatol pmid:26334425
Parsad D et al. A guide to selection and appropriate use of macrolides in skin infections. 2003 Am J Clin Dermatol pmid:12762831